The epidemiology of antibiotic-resistant clinical pathogens in Uganda
ABR is indeed a silent pandemic, and our results suggest it is increasing at 0.5% per year, with a notable surge in 2021 likely due to coronavirus disease 2019 (COVID-19). Of concern, ABR and MDR are mainly associated with bloodstream and surgical wound infections, with a gender and age dimension. However, it is encouraging that carbapenem resistance remains relatively low. Such evidence is critical for contextualising the implementation and evaluation of national action plans.
Authors
- Henry Mwebesa
- Susan Nabadda (ORCID: https://orcid.org/0000-0003-2357-2530)
- Adrian Muwonge (ORCID: https://orcid.org/0000-0002-8579-0384)
- Charles Olaro (ORCID: https://orcid.org/0000-0001-8731-7227)
- Grace Najjuka (ORCID: https://orcid.org/0000-0001-6689-1502)
- Keneth Iceland Kasozi (ORCID: https://orcid.org/0000-0002-5763-7964)
- Aloysious Ssemaganda (ORCID: https://orcid.org/0000-0003-4705-7912)
- Ibrahim Mugerwa (ORCID: https://orcid.org/0000-0003-4462-2867)
- Isaac Ssewanyana (ORCID: https://orcid.org/0000-0001-8605-2001)
- Allan Muruta (ORCID: https://orcid.org/0009-0006-1353-8389)
- Winifred D. Atuhaire
- Ritah Namusoosa (ORCID: https://orcid.org/0009-0001-2743-965X)
Institutions
- Roslin Institute (GB)
- Kabale University (UG)
- Ministry of Health (UG)
- University of Edinburgh (GB)
Publication Details
- Journal
- Journal of Global Health
- Published
- 2024-08-30
- DOI
- https://doi.org/10.7189/jogh.14.04184
- Citations
- 6
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 1.79
Funders
- Biotechnology and Biological Sciences Research Council